Free Delivery Over $100
|
|
|||
|
||||
Overviewon VitalSource (Retail Access Card) on VitalSource (Retail Access Card) Full Product DetailsAuthor: Anat Galor (Associate Professor of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miami, Florida)Publisher: Elsevier - Health Sciences Division Imprint: Elsevier - Health Sciences Division Weight: 0.570kg ISBN: 9780323827539ISBN 10: 0323827535 Pages: 258 Publication Date: 25 January 2022 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Not yet available  This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release. Table of ContentsSection 1: What is Dry Eye Disease (DED)? 1 What is Dry Eye Disease: Evolving Definitions and Epidemiology 2 Questionnaires Used to Assess Dry Eye Disease 3 Clinical Assessment of Dry Eye Disease: Tear Film and Ocular Surface Health 4 Clinical Assessment of Dry Eye Disease: Nerve Health 5 Pathophsiology of Dry Eye Disease using Animal Models 6 Pathophsiology of Dry Eye Disease using Human Models Section 2: Dry Eye Disease (DED) in Specific Populations 7 Sjoegrens and Dry Eye Disease 8 Graft versus Host and Dry Eye Disease 9 Meibomian Gland Dysfunction and Dry Eye Disease 10 Systemic Pain Conditions and Dry Eye Disease 11 Ocular Conditions and Dry Eye Disease Section 3: Treatment of Dry Eye Disease (DEF) 12 Treatment of Dry Eye Disease in the United States 13 Treatment of Dry Eye Disease in Asia 14 Treatment of Dry Eye Disease in Europe 15 Treatment of Ocular Pain Not Responsive to Traditional Dry Eye Disease TreatmentsReviewsAuthor InformationDr. Galor is a cornea and uveitis trained specialist with a dual appointment at the Miami Veterans Affairs (VA) medical center and the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. Dr. Galor completed an ophthalmology residency at the Cole Eye Cleveland Clinic, a uveitis fellowship at the Wilmer Eye Institute, Johns Hopkins University, and a cornea and external diseases fellowship at Bascom Palmer Eye Institute. Dr. Galor currently runs the ocular surface program at the Miami VA and has focused her research on understanding mechanisms of pain in dry eye, with an emphasis on studying new diagnostic and treatment modalities. She has lectured and published extensively on how nerve status may underlie the often noted disconnect between dry eye symptoms and signs. This includes individuals with decreased sensation and chronic epithelial abnormalities (neurotrophic phenotype) and individuals with hyper-sensitive nerves and chronic ocular pain with minimal ocular surface abnormalities (neuropathic phenotype). Over the years, she has participated in several dry eye related committees including the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) II Pain and Sensation Committee and the Dry Eye Awareness Month Congressional Briefing. In addition, she served as President of the Ocular Microbiology and Immunology Group and sits on several educational committees within the Academy of Ophthalmology. Tab Content 6Author Website:Countries AvailableAll regions |
||||
